-
Product Insights
Quarterly Sugar Confectionery pricing trends in the United Kingdom
Consumers' preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement important business choices. GlobalData's new report titled "Quarterly Sugar Confectionery pricing trends in the United Kingdom" serves as a crucial resource...
-
Product Insights
Net Present Value Model: Enweida
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Enweida Drug Details Envafolimab (Enweida) is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – DAB-389EGF
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry DAB-389EGF Drug Details DAB-389-EGF is under development for the treatment of superficial bladder cancer....